1. Wang, Tingjie, Xu, Chuanrui, Zhang, Zhijing, Li, Lei, Ye, Kai. 2022. Cellular heterogeneity and transcriptomic profiles during intrahepatic cholangiocarcinoma initiation and progression. In Hepatology (Baltimore, Md.), 76, 1302-1317. doi:10.1002/hep.32483. https://pubmed.ncbi.nlm.nih.gov/35340039/
2. Xu, Chunjie, Gu, Lei, Kuerbanjiang, Manzila, Zhang, Zhigang, Xu, Qing. 2022. Adaptive activation of EFNB2/EPHB4 axis promotes post-metastatic growth of colorectal cancer liver metastases by LDLR-mediated cholesterol uptake. In Oncogene, 42, 99-112. doi:10.1038/s41388-022-02519-z. https://pubmed.ncbi.nlm.nih.gov/36376513/
3. Zhang, Qianshi, Li, Jing, Liu, Fubing, Zou, Jianfei, Wang, Xiaobin. 2024. Ephrin B2 (EFNB2) potentially protects against intervertebral disc degeneration through inhibiting nucleus pulposus cell apoptosis. In Archives of biochemistry and biophysics, 756, 109990. doi:10.1016/j.abb.2024.109990. https://pubmed.ncbi.nlm.nih.gov/38636690/
4. Mattiske, Deidre, Bernard, Pascal, Gradie, Paul E, Tarulli, Gerard, Pask, Andrew J. 2023. A long non-coding RNA Leat1 mediates the hormone responsiveness of EfnB2 during male urogenital development. In Research square, , . doi:10.21203/rs.3.rs-3098271/v1. https://pubmed.ncbi.nlm.nih.gov/37461443/
5. Lévy, J, Haye, D, Marziliano, N, Verloes, A, Tabet, A-C. 2018. EFNB2 haploinsufficiency causes a syndromic neurodevelopmental disorder. In Clinical genetics, 93, 1141-1147. doi:10.1111/cge.13234. https://pubmed.ncbi.nlm.nih.gov/29508392/
6. Chaudhary, Raushan Kumar, Patil, Prakash, Mateti, Uday Venkat, Alagundagi, Dhananjay B, Shetty, Vijith. 2023. Theranostic Potential of EFNB2 for Cetuximab Resistance in Head and Neck Cancer. In Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 75, 1923-1936. doi:10.1007/s12070-023-03739-9. https://pubmed.ncbi.nlm.nih.gov/37636764/
智鼠故事 
